Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial

NCT02187445 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease
Asthma
Acute Chest Syndrome

Interventions

DRUG: Budesonide inhalation suspension

Sponsor

Vanderbilt University

Collaborators

[object Object]
[object Object]